Asthma Audit Form 2008
14 Pages
English

Asthma Audit Form 2008

-

Downloading requires you to have access to the YouScribe library
Learn all about the services we offer

Description

Blue Cross and Blue Shield of Minnesota R e cog nizing Excellence 2008 Pediatric Asthma Management Audit Form Pay-for-performance program Last updated: 11/17/08 Blue Cross and Blue Shield of Minnesota is a licensee of the Blue Cross and Blue Shield Association 1 2008 Recognizing Excellence (RE) Medical Record Audit Form Numerator Tally PEDIATRIC ASTHMA MANAGEMENT RE criteria met? 1Yes 1No Date of Review: ____/____/___ Reviewer: _______________________ Specialty: Pediatrics Clinic site: ______________________ Clinician ID: ______________ Clinic System:____ _______________ BCBS Member ? 1Yes 1No Clinic Sample ID#: _________ Instructions :Review only the charts that meet the verified inclusion criteria referenced in the criteria summary table (diagnosis of asthma, between ages of 5-18 years, level of asthma severity documented, at least two years of clinic records and dates of service going back 2 years from Dec. 31, 2008). Missing information is considered a NO. Retain this audit tool with your Recognizing Excellence records for reference and validation. Verify Inclusion Criteria: 1. Is the patient between the ages of 5 and 18 as of Dec. 31, 2008 (Date of birth between Dec. 31, 1990 and Dec. 31, 2003)? 1 Yes 1 No If yes, proceed with next question. If no, do not ...

Subjects

Informations

Published by
Reads 19
Language English
1
B l u e
C r o s s
a n d
B l u e
S h i e l d
o f
M in n e s o t a
R e cog nizing
E x c e l l e n c e
2008
Pediatric Asthma Management
Audit
F
o
rm
P
ay-for
-performance
progr
am
Last updated: 11/17/08
Blue
Cross
and
Blue
Shield
of
Minnesota
is
a
licensee
of
the
Blue
Cross
and
Blue
Shield
Association
2
2008 Recognizing Excellence (RE) Medical Record Audit Form
PEDIATRIC ASTHMA MANAGEMENT
Date of Review: ____/____/___
Reviewer: _______________________
Specialty:
Pediatrics
Clinic site: ______________________
Clinician ID: ______________
Clinic System:____ _______________
BCBS Member ?
1
Yes
1
No
Clinic Sample ID#: _________
Instructions :
Review only the charts that meet the verified inclusion criteria referenced in the criteria summary table
(diagnosis of asthma, between ages of 5-18 years, level of asthma severity documented, at least two years of clinic
records and dates of service going back 2 years from Dec. 31, 2008).
Missing information is considered a NO.
Retain this audit tool with your Recognizing Excellence records for reference and validation.
Assess optimal management of the patient with asthma based on the following measures:
1. Is the patient’s asthma severity level documented (see NAEPP guideline for definitions.
NAEPP guidelines can be found
at the following website:
http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm
)?
1
Yes,
complete question 2.
1
No,
stop asthma audit, include this record in the denominator.
2. Is the patient’s asthma severity level documented as
Intermittent
and is it documented that the patient is on a short-
acting Beta
2
Agonist
as needed
(Albuterol, Levalbuterol or Pirbuterol)?
1
Yes,
stop asthma audit, include this record in the numerator and denominator.
1
No, the patient’s asthma severity level is documented as intermittent, but the patient is not on a short-acting
Beta
2
Agonist as needed.
Stop asthma audit, include this record in the denominator.
1
No, patient’s asthma severity level is documented as persistent,
complete question 3.
3.
Is the patient’s asthma severity level documented as
Persistent
and is the patient between the
ages of 5 – 11
as of Dec.
31, 2008 (Date of birth between Dec. 31, 1997 and Dec. 31, 2003)?
1
Yes,
complete question 4
.
1
No, the patient is between the ages of 12 – 18 as of Dec. 31, 2008 (Date of birth between Dec. 31, 1990 and Dec. 31,
1996),
complete question 5.
Numerator Tally
RE criteria met?
1
Yes
1
No
Verify Inclusion Criteria:
1. Is the patient between the ages of 5 and 18 as of Dec. 31, 2008 (Date of birth between Dec. 31, 1990 and Dec. 31, 2003)?
1
Yes
1
No
If yes, proceed with next question.
If no, do not include this record in the denominator. Pull a new medical record from eligible population identified.
2. Is the diagnosis of asthma documented?
1
Yes
1
No
If yes, proceed with next question.
If no, do not include this record in the denominator. Pull a new medical record from eligible population identified.
3. Is this an established patient? (Do you have at least two years of clinic records for this patient?)
1
Yes
1
No
If yes, proceed with next question.
If no, do not include this record in the denominator. Pull a new medical record from eligible population identified.
3
4. Is the
5 – 11
year old
patient being treated with one of the following steps (options 1-7) based on severity level and
control?
1
Yes,
check option boxes and then stop asthma audit, include this record in the numerator and
denominator.
1
No, (option 8)
stop asthma audit, include this record in the denominator.
Mild Persistent
Moderate Persistent
Severe Persistent
1
Option 1 (Preferred)
1
Option 1 (Preferred)
1
Option 1 (Preferred)
Step 2:
Low-Dose ICS
Step 3:
Low-Dose ICS AND LABA
OR
Low-Dose ICS/LABA
Step 5:
High-Dose ICS AND LABA AND
Consultation with Asthma Specialist
OR
High-Dose ICS/LABA AND Consultation
with Asthma Specialist
Choose one from below:
Choose one from each section A + B
OR
choose one from section C
Choose one from each section A + B + D
OR
one from each section C + D
1
Beclomethasone (QVAR)
Section A: Low-Dose ICS
Section A: High-Dose ICS
1
Budesonide DPI (Pulmicort)
1
Beclomethasone (QVAR)
1
Beclomethasone (QVAR)
1
Flunisolide (Aerobid,
Aerobid-M)
1
Budesonide DPI (Pulmicort)
1
Budesonide DPI (Pulmicort)
1
Fluticasone MDI (Flovent)
1
Flunisolide (Aerobid, Aerobid-M)
1
Flunisolide (Aerobid, Aerobid-M)
1
Fluticasone DPI (Flovent
Rotadisk)
1
Fluticasone MDI (Flovent)
1
Fluticasone MDI (Flovent)
1
Triamcinolone Acetonide
(Azmacort)
1
Fluticasone DPI (Flovent Rotadisk)
1
Fluticasone DPI (Flovent Rotadisk)
1
Mometasone (Asmanex)
1
Triamcinolone Acetonide (Azmacort)
1
Triamcinolone Acetonide (Azmacort)
1
Mometasone (Asmanex)
1
Mometasone (Asmanex)
Section B: LABA
Section B: LABA
1
Salmeterol (Serevent)
1
Salmeterol (Serevent)
1
Formoterol Fumarate DPI (Foradil)
1
Formoterol Fumarate DPI (Foradil)
Section C:
Low-Dose ICS/LABA
Section C:
High-Dose ICS/LABA
1
Fluticasone Propionate/Salmeterol
(Advair)
1
Fluticasone Propionate/Salmeterol (Advair)
Section D:
Consult
1
Consultation with Asthma Specialist
Question 4 continued on next page.
4
Mild Persistent
Moderate Persistent
Severe Persistent
1
Option 2 (Alternative)
1
Option 2 (Alternative)
1
Option 2 (Alternative)
Step 2:
Leukotriene Modifier
Step 3:
Low-Dose ICS AND Leukotriene
Modifier
Step 5:
High-Dose ICS AND Leukotriene Modifier
AND Consultation with Asthma Specialist
Choose one from below:
Choose one from each section A + B
Choose one from each section A + B + C
1
Montelukast (Singulair)
Section A: Low-Does ICS
Section A: High-Dose ICS
1
Zafirlukast (Accolate)
1
Beclomethasone (QVAR)
1
Beclomethasone (QVAR)
1
Budesonide DPI (Pulmicort)
1
Budesonide DPI (Pulmicort)
1
Flunisolide (Aerobid, Aerobid-M)
1
Flunisolide (Aerobid, Aerobid-M)
1
Fluticasone MDI (Flovent)
1
Fluticasone MDI (Flovent)
1
Fluticasone DPI (Flovent Rotadisk)
1
Fluticasone DPI (Flovent Rotadisk)
1
Triamcinolone Acetonide (Azmacort)
1
Triamcinolone Acetonide (Azmacort)
1
Mometasone (Asmanex)
1
Mometasone (Asmanex)
Section B:
Leukotriene Modifier
Section B:
Leukotriene Modifier
1
Montelukast (Singulair)
1
Montelukast (Singulair)
1
Zafirlukast (Accolate)
1
Zafirlukast (Accolate)
Section C: Consult
1
Consultation with Asthma Specialis
t
1
Option 3 (Alternative)
1
Option 3 (Alternative)
1
Option 3 (Alternative)
Step 2:
Cromolyn or Nedocromil
Step 3:
Low-Dose ICS AND Theophylline
Step 5:
High-Dose ICS AND Theophylline AND
Consultation with Asthma Specialist
Choose one from below:
Choose one from each section A + B
Choose one from each section A + B + C
1
Cromolyn (Intal)
Section A: Low-Dose ICS
Section A: High-Dose ICS
1
Nedocromil (Tilade)
1
Beclomethasone (QVAR)
1
Beclomethasone (QVAR)
1
Budesonide DPI (Pulmicort)
1
Budesonide DPI (Pulmicort)
1
Flunisolide (Aerobid, Aerobid-M)
1
Flunisolide (Aerobid, Aerobid-M)
1
Fluticasone MDI (Flovent)
1
Fluticasone MDI (Flovent)
1
Fluticasone DPI (Flovent Rotadisk)
1
Fluticasone DPI (Flovent Rotadisk)
1
Triamcinolone Acetonide (Azmacort)
1
Triamcinolone Acetonide (Azmacort)
1
Mometasone (Asmanex)
1
Mometasone (Asmanex)
Section B: Theophylline
Section B:
Theophylline
1
Methylxanthines (Theophylline)
1
Methylxanthines (Theophylline)
Section C: Consult
1
Consultation with Asthma Specialist
Question 4 continued on next page.
5
Mild Persistent
Moderate Persistent
Severe Persistent
1
Option 4 (Alternative)
1
Option 4 (Alternative)
1
Option 4 (Preferred)
Step 2:
Theophylline
Step 3:
Medium-Dose ICS
Step 6:
High-Dose ICS AND LABA AND Oral
Systemic Corticosteroid AND Consultation
with Asthma Specialist
OR
High-Dose ICS/LABA AND Oral Systemic
Corticosteroid AND Consultation with
Asthma Specialist
Choose one from below:
Choose one from below:
Choose one from each section A + B + D + E
OR
one from each section C + D + E
1
Methylxanthines
(Theophylline)
1
Beclomethasone (QVAR)
Section A: High-Dose ICS
1
Budesonide DPI (Pulmicort)
1
Beclomethasone (QVAR)
1
Flunisolide (Aerobid, Aerobid-M)
1
Budesonide DPI (Pulmicort)
1
Fluticasone MDI (Flovent)
1
Flunisolide (Aerobid, Aerobid-M)
1
Fluticasone DPI (Flovent Rotadisk)
1
Fluticasone MDI (Flovent)
1
Triamcinolone Acetonide (Azmacort)
1
Fluticasone DPI (Flovent Rotadisk)
1
Mometasone (Asmanex)
1
Triamcinolone Acetonide (Azmacort)
1
Mometasone (Asmanex)
Section B: One or more LABA
1
Salmeterol (Serevent)
1
Formoterol Fumarate DPI (Foradil)
Section C:
High-Dose ICS/LABA
1
Fluticasone Propionate/Salmeterol (Advair)
Section D: Oral Systemic Corticosteroid
1
Methylprednisolone
1
Prednisolone
1
Prednisone
Section E: Consult
1
Consultation with Asthma Specialist
Question 4 continued on next page.
6
Mild Persistent
Moderate Persistent
Severe Persistent
1
Option 5 (Alternative)
1
Option 5 (Preferred)
1
Option 5 (Alternative)
Step 1:
(If mild persistent patient has
been well controlled for 3
months, may step down to
this step)
Short-acting
Beta
2
Agonist
as
needed
Step 4:
Medium-Dose ICS AND LABA AND
Consultation with Asthma Specialist
OR
Medium- Dose ICS/LABA AND
Consultation with Asthma Specialist
Step 6:
High-Dose ICS AND Theophylline AND Oral
Systemic Corticosteroid AND Consultation
with Asthma Specialist
Choose one from below:
Choose one from each section
A + B + D
OR
one from each section C + D
Choose one from each section A + B + C + D
1
Albuterol (ProAir HFA,
Proventil HFA and Ventolin
HFA, AccuNeb)
Section A: Medium-Dose ICS
Section A: High-Dose ICS
1
Levalbuterol (Xopenex HFA,
Xopenex)
1
Beclomethasone (QVAR)
1
Beclomethasone (QVAR)
1
Pirbuterol (Maxair)
1
Budesonide DPI (Pulmicort)
1
Budesonide DPI (Pulmicort)
1
Flunisolide (Aerobid, Aerobid-M)
1
Flunisolide (Aerobid, Aerobid-M)
1
Fluticasone MDI (Flovent)
1
Fluticasone MDI (Flovent)
1
Fluticasone DPI (Flovent Rotadisk)
1
Fluticasone DPI (Flovent Rotadisk)
1
Triamcinolone Acetonide (Azmacort)
1
Triamcinolone Acetonide (Azmacort)
1
Mometasone (Asmanex)
1
Mometasone (Asmanex)
Section B:
LABA
Section B: Theophylline
1
Salmeterol (Serevent)
1
Methylxanthines (Theophylline)
1
Formoterol Fumarate DPI (Foradil)
Section C:
Medium-Dose ICS/LABA
Section C: Oral Systemic Corticosteroid
1
Fluticasone Propionate/Salmeterol
(Advair)
1
Methylprednisolone
1
Prednisolone
1
Prednisone
Section D: Consult
Section D: Consult
1
Consultation with Asthma Specialist
1
Consultation with Asthma Specialist
Question 4 continued on next page.
7
Mild Persistent
Moderate Persistent
Severe Persistent
1
Option 6 (Alternative)
1
Option 6 (Alternative)
Step 4:
Medium-Dose ICS AND Leukotriene
Modifier AND Consultation with
Asthma Specialist
Step 6:
High-Dose ICS AND Leukotriene Modifier
AND Oral Systemic Corticosteroid AND
Consultation with Asthma Specialist
Choose one from each section
A + B + C
Choose one from each section A + B + C + D
Section A:
Medium-Dose ICS
Section A: High-Dose ICS
1
Beclomethasone (QVAR)
1
Beclomethasone (QVAR)
1
Budesonide DPI (Pulmicort)
1
Budesonide DPI (Pulmicort)
1
Flunisolide (Aerobid, Aerobid-M)
1
Flunisolide (Aerobid, Aerobid-M)
1
Fluticasone MDI (Flovent)
1
Fluticasone MDI (Flovent)
1
Fluticasone DPI (Flovent Rotadisk)
1
Fluticasone DPI (Flovent Rotadisk)
1
Triamcinolone Acetonide (Azmacort)
1
Triamcinolone Acetonide (Azmacort)
1
Mometasone (Asmanex)
1
Mometasone (Asmanex)
Section B: Leukotriene Modifier
Section B: Leukotriene Modifier
1
Montelukast (Singulair)
1
Montelukast (Singulair)
1
Zafirlukast (Accolate)
1
Zafirlukast (Accolate)
Section C: Consult
Section C:
Oral Systemic Corticosteroid
1
Consultation with Asthma Specialist
1
Methylprednisolone
1
Prednisolone
1
Prednisone
Section D: Consult
1
Consultation with Asthma Specialist
1
Option 7 (Alternative)
Step 4:
Medium-Dose ICS AND Theophylline
AND Consultation with Asthma
Specialist
Choose one from each section
A + B + C
Section A:
Medium-Dose ICS
1
Beclomethasone (QVAR)
1
Budesonide DPI (Pulmicort)
1
Flunisolide (Aerobid, Aerobid-M)
1
Fluticasone MDI (Flovent)
1
Fluticasone DPI (Flovent Rotadisk)
1
Triamcinolone Acetonide (Azmacort)
1
Mometasone (Asmanex)
Section B: Theophylline
1
Methylxanthines (Theophylline)
Section C: Consult
1
Consultation with Asthma Specialist
Question 4 continued on next page.
8
Mild Persistent
Moderate Persistent
Severe Persistent
1
Option 8
1
Option 8
1
Option 8
None of the above
None of the above
None of the above
5.
Is the
12 – 18
year old
patient being treated with one of the following steps (options 1-7) based on severity level and
control?
1
Yes,
check option boxes and then stop asthma audit, include this record in the numerator and denominator.
1
No (option 8),
stop asthma audit, include this record in the denominator.
Mild Persistent
Moderate Persistent
Severe Persistent
1
Option 1 (Preferred)
1
Option 1 (Preferred)
1
Option 1 (Preferred)
Step 2:
Low-Dose ICS
Step 3:
Low-Dose ICS AND LABA
OR
Low-Dose ICS/LABA
Step 5:
High-Dose ICS AND LABA AND
Consultation with Asthma Specialist
OR
High-Dose ICS/LABA AND Consultation
with Asthma Specialist
Choose one from below:
Choose one from each section A + B
OR
one from Section C
Choose one from each section A + B + D
OR
one from each section C + D
1
Beclomethasone (QVAR)
Section A: Low-Dose ICS
Section A: High-Dose ICS
1
Budesonide DPI (Pulmicort)
1
Beclomethasone (QVAR)
1
Beclomethasone (QVAR)
1
Flunisolide (Aerobid,
Aerobid-M)
1
Budesonide DPI (Pulmicort)
1
Budesonide DPI (Pulmicort)
1
F
luticasone MDI (Flovent)
1
Flunisolide (Aerobid, Aerobid-M)
1
Flunisolide (Aerobid, Aerobid-M)
1
Fluticasone DPI (Flovent
Rotadisk)
1
Fluticasone MDI (Flovent)
1
Fluticasone MDI (Flovent)
1
Triamcinolone Acetonide
(Azmacort)
1
Fluticasone DPI (Flovent Rotadisk)
1
Fluticasone DPI (Flovent Rotadisk)
1
Mometasone (Asmanex)
1
Triamcinolone Acetonide (Azmacort)
1
Triamcinolone Acetonide (Azmacort)
1
Mometasone (Asmanex)
1
Mometasone (Asmanex)
Section B: LABA
Section B: One or more LABA
1
Salmeterol (Serevent)
1
Salmeterol (Serevent)
1
Formoterol Fumarate DPI (Foradil)
1
Formoterol Fumarate DPI (Foradil)
Section C:
Low-Dose ICS/LABA
Section C:
High-Dose ICS/LABA
1
Fluticasone Propionate/Salmeterol
(Advair)
1
Fluticasone Propionate/Salmeterol (Advair)
1
Budesonide/formoterol (Symbicort)
1
Budesonide/formoterol (Symbicort)
Section D: Consult
1
Consultation with Asthma Specialist
Question 5 continued on next page.
9
Mild Persistent
Moderate Persistent
Severe Persistent
1
Option 2 (Alternative)
1
Option 2
(Alternative)
1
Option 2
(Alternative)
Step 2:
Leukotriene Modifier
Step 3:
Low-Dose ICS AND Leukotriene
Modifier
Step 5:
High-Dose ICS AND LABA AND
Leukotriene Modifier
AND Consultation
with Asthma Specialist
OR
High-Dose ICS/LABA AND
Leukotriene
Modifier
AND Consultation with Asthma
Specialist
Choose one from below:
Choose one from each section A +B
Choose one from each section A + B + D + E
OR
one from each section C + D + E
Section A: Low-Does ICS
Section A: High-Dose ICS
1
Montelukast (Singulair)
1
Beclomethasone (QVAR)
1
Beclomethasone (QVAR)
1
Zafirlukast (Accolate)
1
Budesonide DPI (Pulmicort)
1
Budesonide DPI (Pulmicort)
1
Zileuton (Zyflo)
1
Flunisolide (Aerobid, Aerobid-M)
1
Flunisolide (Aerobid, Aerobid-M)
1
Fluticasone MDI (Flovent)
1
Fluticasone MDI (Flovent)
1
Fluticasone DPI (Flovent Rotadisk)
1
Fluticasone DPI (Flovent Rotadisk)
1
Triamcinolone Acetonide (Azmacort)
1
Triamcinolone Acetonide (Azmacort)
1
Mometasone (Asmanex)
1
Mometasone (Asmanex)
Section B:
Leukotriene Modifier
Section B: LABA
1
Montelukast (Singulair)
1
Salmeterol (Serevent)
1
Zafirlukast (Accolate)
1
Formoterol Fumarate DPI (Foradil)
1
Zileuton (Zyflo)
Section C:
High-Dose ICS/LABA
1
Fluticasone Propionate/Salmeterol (Advair)
1
Budesonide/formoterol (Symbicort)
Section D:
Leukotriene Modifier
1
Montelukast (Singulair)
1
Zafirlukast (Accolate)
1
Zileuton (Zyflo)
Section E: Consult
1
Consultation with Asthma Specialist
Question 5 continued on next page.
10
Mild Persistent
Moderate Persistent
Severe Persistent
1
Option 3 (Alternative)
1
Option 3 (Alternative)
1
Option 3 (Preferred)
Step 2:
Cromolyn/Nedocromil
Step 3:
Low-Dose ICS AND Theophylline
Step 6:
High-Dose ICS AND LABA AND Oral
Systemic Corticosteroid AND Consultation
with Asthma Specialist
OR
High-Dose ICS/LABA AND Oral Systemic
Corticosteroid AND Consultation with
Asthma Specialist
Choose one from below:
Choose one from each section A + B
Choose one from each section
A + B + D + E
OR
one from each section C + D + E
1
Cromolyn (Intal)
Section A: Low-Dose ICS
Section A: High-Dose ICS
1
Nedocromil (Tilade)
1
Beclomethasone (QVAR)
1
Beclomethasone (QVAR)
1
Budesonide DPI (Pulmicort)
1
Budesonide DPI (Pulmicort)
1
Flunisolide (Aerobid, Aerobid-M)
1
Flunisolide (Aerobid, Aerobid-M)
1
Fluticasone MDI (Flovent)
1
Fluticasone MDI (Flovent)
1
Fluticasone DPI (Flovent Rotadisk)
1
Fluticasone DPI (Flovent Rotadisk)
1
Triamcinolone Acetonide (Azmacort)
1
Triamcinolone Acetonide (Azmacort)
1
Mometasone (Asmanex)
1
Mometasone (Asmanex)
Section B: Theophylline
Section B: LABA
1
Methylxanthines (Theophylline)
1
Salmeterol (Serevent)
1
Formoterol Fumarate DPI (Foradil)
Section C:
High-Dose ICS/LABA
1
Fluticasone Propionate/Salmeterol (Advair)
1
Budesonide/formoterol (Symbicort)
Section D:
Oral Systemic Corticosteroid
1
Methylprednisolone
1
Prednisolone
1
Prednisone
Section E: Consult
1
Consultation with Asthma Specialist
Question 5 continued on next page.
11
Mild Persistent
Moderate Persistent
Severe Persistent
1
Option 4 (Alternative)
1
Option 4 (Alternative)
1
Option 4 (Alternative)
Step 2:
Theophylline
Step 3:
Medium-Dose ICS
Step 6:
High-Dose ICS AND LABA AND Oral
Systemic Corticosteroid AND Leukotriene
Modifier AND Consultation with Asthma
Specialist
OR
High-Dose ICS/LABA AND Oral Systemic
Corticosteroid AND Leukotriene Modifier
AND Consultation with Asthma Specialist
Choose one from below:
Choose one from below:
Choose one from each section
A + B + D + E + F
OR
one from each section C + D + E + F
1
Methylxanthines
(Theophylline)
1
Beclomethasone (QVAR)
Section A: High-Dose ICS
1
Budesonide DPI (Pulmicort)
1
Beclomethasone (QVAR)
1
Flunisolide (Aerobid, Aerobid-M)
1
Budesonide DPI (Pulmicort)
1
Fluticasone MDI (Flovent)
1
Flunisolide (Aerobid, Aerobid-M)
1
Fluticasone DPI (Flovent Rotadisk)
1
Fluticasone MDI (Flovent)
1
Triamcinolone Acetonide (Azmacort)
1
Fluticasone DPI (Flovent Rotadisk)
1
Mometasone (Asmanex)
1
Triamcinolone Acetonide (Azmacort)
1
Mometasone (Asmanex)
Section B: LABA
1
Salmeterol (Serevent)
1
Formoterol Fumarate DPI (Foradil)
Section C:
High-Dose ICS/LABA
1
Fluticasone Propionate/Salmeterol (Advair)
1
Budesonide/formoterol (Symbicort)
Section D:
Oral Systemic Corticosteroid
1
Methylprednisolone
1
Prednisolone
1
Prednisone
Section E:
Leukotriene Modifier
1
Montelukast (Singulair)
1
Zafirlukast (Accolate)
1
Zileuton (Zyflo)
Section F: Consult
1
Consultation with Asthma Specialist
Question 5 continued on next page.